Correspondence
(5241)
Articles and Commentaries
(4276)
Major Articles
(3004)
BRIEF REPORTS
(2168)
HIV/AIDS
(1801)
Major Article
(1688)
Clinical Articles
(1426)
supplement articles
(1337)
Online only articles
(1038)
MAJOR ARTICLES AND COMMENTARIES
(776)
Review Articles
(702)
Clinical Infectious Disease Articles
(638)
Electronic Articles
(620)
Articles
(604)
Brief Reports
(594)
Notes
(555)
Brief Report
(542)
Photo Quiz
(530)
Original Article
(503)
In the Literature
(465)
INVITED ARTICLES
(459)
News
(435)
Book Reviews
(416)
Editorial Commentaries
(407)
Major Articles and Commentaries
(399)
Viewpoints
(370)
Invited Article
(356)
Errata
(326)
Editorial Commentary
(314)
Review Article
(279)
Answer To The Photo Quiz
(258)
Erratum
(193)
Supplement Article
(163)
Healthcare Epidemiology
(155)
Notices
(139)
In This Issue
(134)
Vaccines
(110)
State-of-the-Art Clinical Article
(104)
Answer to Photo Quiz
(101)
IDSA Guideline
(101)
Book Review
(95)
Correction
(91)
Invited Articles
(87)
Correspondences
(85)
Clinical Practice
(84)
Immunocompromised Hosts
(84)
Letter Reply
(83)
Antimicrobial Resistance and Stewardship
(81)
Statement of Editorial Policy
(80)
Introduction
(79)
Clinical Notes
(76)
ELECTRONIC ARTICLE
(74)
Supplement Articles
(74)
Emerging Infections
(73)
Reviews of Anti-Infective Agents
(70)
Serial Features
(65)
HIV/AIDS Collection
(62)
Viewpoints Article
(60)
Letter Re: Published Article
(58)
Food Safety
(57)
Classics in Infectious Diseases
(48)
Antimicrobial Resistance
(46)
Mycobacterial Infections
(46)
Abstracts for Electronic Articles
(45)
AIDS Commentary
(42)
INVITED COMMENTARY
(42)
Medical Microbiology
(42)
International Symposium on the Prevention of Congenital Rubella Infection
(41)
Covid Testing
(40)
International Symposium on Vaccine Development and Utilization
(40)
New Developments in Resistance to β-Lactam Antibiotics among Nonfastidious Gram-Negative Organisms
(40)
Aging and Infectious Diseases
(37)
Bacterial Infections
(37)
Hepatitis
(37)
Letter
(36)
State-of-the-Art Review
(36)
Voices of ID
(36)
Clinical Trials
(35)
Travel Medicine
(35)
Checklist of Information for Inclusion in Reports of Clinical Trials
(34)
Clinical Practice and Policy
(34)
Editorial
(34)
COVID-19/SARS-CoV-2
(33)
Covid Treatment and Management
(33)
Molecular Concepts of Lipid A
(33)
Tuberculosis
(33)
Anaerobic Infections
(32)
Clinical Infection
(31)
Perspective on Bacterial Pathogenesis and Host Defense
(31)
THE MENINGITIS VACCINE PROJECT: THE DEVELOPMENT, LICENSURE, INTRODUCTION, AND IMPACT OF A NEW GROUP A MENINGOCOCCAL CONJUGATE VACCINE FOR AFRICA
(31)
Respiratory Infections
(30)
International Report
(29)
Session III: Strategies For Control
(29)
IDSA Guidelines
(28)
Respiratory Viral Infections
(28)
IDSA Features
(27)
Session II
(27)
Session III
(27)
HISTORICAL ARTICLE
(26)
Vaccines, Variants, and Vigilance Supplement
(26)
Confronting Biological Weapons
(24)
Control Programs
(24)
Fungal Infections
(24)
Session I
(24)
Checklist for Submitted Manuscripts
(23)
International Reports
(23)
Appendix A
(22)
Infectious Disease Rounds
(22)
Guidelines from the Infectious Diseases Society of America
(21)
COVID-19 / SARS Cov-2
(20)
HIV/Aids
(20)
International Notes
(20)
Precision Vaccines Supplement
(20)
Session IV: Current Research
(20)
Surfing the Web
(20)
Vector-Borne Diseases Collection
(20)
COVID-19/SARS CoV-2
(19)
Clinical Infectious Disease Article
(19)
Hypothesis
(19)
INVASIVE SALMONELLA DISEASE IN AFRICA
(19)
Part II: Clinical and Multidisciplinary Research on Chronic Fatigue Syndrome
(19)
THE MALNUTRITION AND ENTERIC DISEASE STUDY (MAL-ED): UNDERSTANDING THE CONSEQUENCES FOR CHILD HEALTH AND DEVELOPMENT
(19)
Tuberculosis Commentary
(19)
Poster Session
(18)
Session II: Clinical Pharmacology and Clinical Use
(18)
Sexually Transmitted Infections (non-HIV/AIDS)
(18)
VIDA Supplement
(18)
Clinical Bacteriology
(17)
Diagnostic Microbiology Updates
(17)
Historical Articles
(17)
INFANT PERTUSSIS DISEASE BURDEN IN THE CONTEXT OF MATERNAL IMMUNIZATION STRATEGIES
(17)
List of Abbreviations
(17)
Oral and Dental Disease
(17)
Pathogenesis
(17)
Pediatric and Maternal Infectious Diseases
(17)
Problems Posed by Specific Parasitic Diseases
(17)
Susceptibility Testing
(17)
ADVANCES IN TUBERCULOSIS RESEARCH: A BLUEPRINT FOR OPPORTUNITIES
(16)
Articles and Commentary
(16)
Clinical Reports
(16)
Crossing Borders: One World, Global Health
(16)
Endovascular Infections
(16)
Focus on Fungal Infections 5
(16)
Global Health and Neglected Tropical Diseases
(16)
Guest Editors and Sponsor
(16)
IV. Clinical Studies
(16)
Infection Control and Hospital Epidemiology
(16)
International Conference on Acute Respiratory Infections
(16)
Session I: Current Impact of Measles
(16)
THE DEVELOPMENT, LICENSURE, AND INTRODUCTION OF MENAFRIVAC
(16)
Viewpoint
(16)
A Seminar on Infant Botulism
(15)
Africa
(15)
Anaerobic Bacteria
(15)
Factors and Mechanisms of Bacterial Virulence or Pathogenicity
(15)
Lyme Disease and other Spirochetal Diseases
(15)
Perspective
(15)
Properties and Characteristics of a New Immunoglobulin G Intravenous Preparation
(15)
Second International Workshop on Helicobacter pylori Infections in the Developing World
(15)
Session I: Basic Science
(15)
Session III: Current Measles Control
(15)
Session VI: Clinical Aspects
(15)
Specific Infections
(15)
TYPHOID FEVER SURVEILLANCE IN AFRICA PROGRAM (TSAP)
(15)
Trachoma
(15)
Update and Advances in Intravenous Therapy with Trimethoprim-Sulfamethoxazole
(15)
ANTIMICROBIAL STEWARDSHIP: PATIENTS OVER PROCESS
(14)
Abstracts
(14)
Books Received
(14)
Corrections
(14)
Covid Transmission Collection
(14)
Cytomegalovirus Infection and Treatment with Ganciclovir
(14)
Emerging Concepts and Strategies in Clinical Microbiology and Infectious Diseases
(14)
HIV Infection, AIDS, and Mycoplasmal Infection in Immunocompromised Hosts
(14)
Molecular Mechanisms of Microbial Host Cell Interactions in Periodontal Disease
(14)
Part 1: Epidemiology of Chronic Fatigue Syndrome
(14)
Recent Increases in Resistance: Mechanisms and Organisms
(14)
Session I: Synergy and Combinations
(14)
Session II: Measles Vaccines
(14)
Session IV
(14)
Significance of Subminimal Inhibitory Concentrations of Antibiotics: A Symposium
(14)
Susceptibility Testing, Antimicrobial Resistance, and Therapy
(14)
Use of Live Attenuated Vaccine
(14)
Articles and Commenaries
(13)
CONTROLLING THE HIV EPIDEMIC WITH ANTIRETROVIRALS
(13)
Fibronectin and the Pathogenesis of Infections
(13)
Innovations in Design, Education and Analysis (IDEA)
(13)
Integrating Geriatrics into Rheumatology, Infectious Diseases, and Immunology
(13)
Invited Reviews
(13)
LEAP Supplement
(13)
MISCELLANY
(13)
PROBIOTICS: ADDED SUPPLEMENTARY VALUE IN CLOSTRIDIUM DIFFICILE INFECTION
(13)
Photo Quiz Answer
(13)
SEROLOGIC AND SAFETY STUDIES OF A GROUP A MENINGOCOCCAL CONJUGATE VACCINE
(13)
Session I: Definition of the Problem
(13)
Susceptibility Testing, Resistance, and Resistance Mechanisms
(13)
ADVANCES AND NEW DIRECTIONS FOR ECHINOCANDINS
(12)
Antimicrobial Spectrum and Clinical Trials with Cefsulodin
(12)
Brief Reports and Commentaries
(12)
CSE Theme Article
(12)
II. Clinical and Epidemiologic Aspects of Infectious Diseases in Child Day Care
(12)
Microbiology Section
(12)
Mollicutes: Mycoplasma Pneumoniae and Mycoplasma Genitalium
(12)
Pathogenesis and Virulence Factors
(12)
Session II: Poliovirus Vaccines
(12)
Session III: Host Defense Against the Pneumococcus
(12)
Session V: Genitourinary Tract Infections
(12)
Special Section: HIV/AIDS
(12)
Surfing The Web
(12)
Symposium Articles
(12)
VIRAL HEPATITIS
(12)
Viruses, Infection, and Hemostasis
(12)
Animal Models
(11)
Author Index
(11)
COVID Testing
(11)
Corrigenda
(11)
EVIDENCE PAPERS FOR THE CDC SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES
(11)
General Topics Concerning Anaerobes
(11)
HIV POSTEXPOSURE PROPHYLAXIS
(11)
Mediators/Pathogenesis
(11)
Prospects for New Viral Vaccines: A Symposium
(11)
Session II: Evaluation of Cefoperazone
(11)
Session II: Toxicity and Pharmacokinetics of Moxalactam
(11)
Session III: New Vaccines
(11)
Session V
(11)
State-of-the-Art Clinical Articles
(11)
The Burden of Group B Streptococcus Worldwide for Pregnant Women, Stillbirths, and Children
(11)
Ureaplasma Urealyticum Respiratory Disease in Newborns
(11)
Addressing Issues of Antimicrobial Resistance
(10)
Adolescent Voluntary Medical Male Circumcision: Vital Intervention Yet Improvements Needed
(10)
Basic Bacteriology
(10)
Brief Reports and Commentary
(10)
Education and Training
(10)
Epidemiology and Social Science Perspectives
(10)
Hot Page
(10)
IDSA Lecture
(10)
IDSA Public Policy
(10)
Microbiology and Genetics
(10)
Microbiology of Acanthamoeba: Extended Abstracts
(10)
Onchocerciasis
(10)
Session 6: Novel β-Lactamases and Other New Developments in Resistance to β-Lactam Antibiotics
(10)
Session I: Empiric Therapy for Bacterial Infections
(10)
Session I: History, Bacteriology, and Animal Toxicity
(10)
Session II. Clinical Studies
(10)
Session II: Epidemiology of Rubella and Congenital Rubella Infection
(10)
TSST-l: Regulation and Control
(10)
Acanthamoeba and Contact Lenses: Extended Abstracts
(9)
Advanced HIV Disease
(9)
Antipyretic Therapy
(9)
Bacampicillin: Clinical Studies
(9)
CME Information
(9)
Clinical and Epidemiologic Aspects
(9)
Corrigendum
(9)
Domestic Animal Rabies Control
(9)
Emanuel Wolinsky Award
(9)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Gastrointestinal Infections
(9)
III. Fungal Infections in Dermatology
(9)
Immunogenicity
(9)
Instructions to authors
(9)
Serial Feature
(9)
Session IV: Clinical Efficacy and Safety of Imipenem/Cilastatin
(9)
Session IV: Use of Moxalactam in Surgical Patients
(9)
Session VI
(9)
Special article
(9)
Systemic Infection Involving Anaerobes
(9)
THE SANITATION HYGIENE INFANT NUTRITION EFFICACY (SHINE) TRIAL
(9)
Viral Infections
(9)
Wildlife Rabies: Ecology and Epidemiology
(9)
A DEVELOPMENT PARADIGM FOR NOVEL COMBINATION REGIMENS FOR MULTIDRUG-RESISTANT AND DRUG-SUSCEPTIBLE TUBERCULOSIS IN CHILDREN: FLAME FOR WORK AND PLAY
(8)
Abstract for Electronic Articles
(8)
Argentina
(8)
Aricles and Commentaries
(8)
Article
(8)
CDC MODELING EFFORTS IN RESPONSE TO A POTENTIAL PUBLIC HEALTH EMERGENCY: INFLUENZA A(H7N9) AS AN EXAMPLE
(8)
CME Questions
(8)
Clinical Manifestations and Management
(8)
Covid-19 / Sars Cov-2
(8)
Experimental Infections
(8)
FACILITATING ANTIBACTERIAL DRUG DEVELOPMENT IN A TIME OF GREAT NEED
(8)
HEALTHCARE WORKERS AND TUBERCULOSIS PREVENTION
(8)
Human Rabies and Its Prevention
(8)
II. Deep Mycoses and Opportunistic Infections
(8)
In Memoriam
(8)
Index
(8)
Measles Mortality
(8)
New Directions in Human Immunodeficiency Virus Therapy and Quality Survival
(8)
PRENATAL THERAPY OF CONGENITAL CYTOMEGALOVIRUS INFECTION
(8)
Pediatric Infections
(8)
Pharmacodynamics of Antimicrobials
(8)
Problems in Design and Analysis
(8)
Session I: Strategy for Vaccine Delivery
(8)
Session II. Discovery, Development, and Properties of Aztreonam
(8)
Session III: Rubella Vaccines
(8)
Session V: Prospects for Worldwide Control
(8)
Session VI: Immunization Strategies
(8)
Session VIII
(8)
Statement of Editorial Policy and Instructions to Authors
(8)
Surgical Infectious Diseases
(8)
Susceptibility Testing of Antimicrobial Agents
(8)
TEDIZOLID - A NOVEL OXAZOLIDINONE FOR GRAM-POSITIVE INFECTIONS
(8)
Advances in Molecular Epidemiology
(7)
African Hemorrhagic Fevers
(7)
Antibiotic use and Antibiotic Resistance Worldwide
(7)
Antimicrobial Agents: Susceptibility Testing, Effects, Prophylaxis, and Therapy
(7)
Antimicrobial Resistance in Streptococcus pneumoniae
(7)
Approaches to Collection of Data
(7)
Clinical Section
(7)
Clinical Studies
(7)
Conclusions
(7)
Emerging Resistance with Gram-Positive Aerobic Infections: Where Do We Go from Here?
(7)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Sexually Transmitted Diseases
(7)
History
(7)
Immunomodulation in the Treatment of Invasive Fungal Infections: Present and Future Directions
(7)
Management of the Immunocompromised Patient: Impact of Fungal Infections
(7)
Miscellaneous Topics
(7)
NOTE
(7)
Part IV: Immunologic Studies of Chronic Fatigue Syndrome
(7)
Pathophysiology and Epidemiology of Infection by Helicobacter pylori
(7)
Pharmacology of Acanthamoeba: Extended Abstracts
(7)
Prevention with Use of Vaccines
(7)
Prophylaxis and Treatment of Mycoses
(7)
Session 3: Mechanisms Responsible for multiple β-Lactam Resistance Following Derepression of β-Lactamases
(7)
Session 4: Genetics and Control of β-Lactamase Expression
(7)
Session I: Chemistry and in Vitro Activity of Moxalactam and Mechanisms of Resistance
(7)
Session II: Aminoglycoside Antibiotics: Resistance and Toxicity
(7)
Session II: Epidemiology of Pneumococcal Disease
(7)
Session IV: Operational Issues
(7)
Session V: Immunologic Response of High-Risk Patients to Pneumococcal Vaccine
(7)
Session V: Systemic Mycoses
(7)
Special Section/Invited Article
(7)
Special Section: Travel Medicine
(7)
Surveillance and control of pathogens of epidemiologic importance
(7)
TELAVANCIN: TREATMENT FOR GRAM-POSITIVE INFECTIONS-NEW PERSPECTIVES ON IN VITRO AND CLINICAL DATA
(7)
THE JOHN BARTLETT FESTSCHRIFT: CELEBRATING A CAREER IN MEDICINE
(7)
THE THIRD INFECTIONS IN CANCER SYMPOSIUM
(7)
TSST-1: Structure, Function, Purification, and Detection
(7)
The Nature of Problem Bacteria: Is Resistance Enough?
(7)
AN EVIDENCE-BASED DRUG DEVELOPMENT TOOL FOR TUBERCULOSIS REGIMENS: THE HOLLOW FIBER SYSTEM MODEL
(6)
Bone and Joint Infections—An Update
(6)
COVID RWD Supplement
(6)
Clostridium Difficile Enteric Disease
(6)
Consensus/Discussion Groups
(6)
Critical Care and Sepsis
(6)
Current Issues in the Management of Febrile Neutropenia
(6)
Dengue and Kyasanur Forest Disease
(6)
EPIDEMIOLOGY
(6)
Editorials
(6)
Epidemiology of Acute Respiratory Tract Infections in Children
(6)
Fungal Infections in Normal Hosts
(6)
General Concepts
(6)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Skin, Skin-Structure, Bone, and Joint Infections
(6)
Hepatitis B
(6)
Hospital-Based Studies on Acute Respiratory Tract Infections in Young Children
(6)
III. In Vitro Studies of Susceptibility and Resistance and Animal Models of Infection
(6)
INCLUDING PREGNANT WOMEN IN CLINICAL TRIALS OF ANTIMICROBIALS AND VACCINES
(6)
IV. Treatment
(6)
Immune Parameters in HSV Infection
(6)
Indigenous Flora
(6)
Infectious Diseases Update: 1982 Excerpts from a Symposium
(6)
Introduction and Mechanism
(6)
Miscellaneous Infections
(6)
Molecular Biology of Rabies Virus
(6)
Nononcogenic Retrovirus Infections as Models for Chronic and Relapsing Human Diseases: A Collection of Papers
(6)
ORIGINAL CONTRIBUTIONS
(6)
Online only
(6)
Overview of Fungal Infections
(6)
Pathogenesis and Immune Mechanisms of Anaerobic Infections
(6)
Pathogenesis of Infection by Helicobacter pylori
(6)
Pathogenesis of Tuberculosis and Its Implications for Vaccine Development
(6)
Patients With T Cell Defects: Part 2
(6)
Procedimentos De La Conferencia
(6)
SARS-CoV-2 Testing
(6)
SUL-DUR Supplement
(6)
Session 2: Biochemistry of β-Lactamases and Penicillin-Binding Proteins
(6)
Session I: Membrane Organization
(6)
Session I: The Pneumococcus
(6)
Session II. Respiratory Tract Infections
(6)
Session II: Clinical Uses of Prophylaxis
(6)
Session II: Trimethoprim
(6)
Session III: Bacteriology
(6)
Session III: Research Needs
(6)
Session III: Use of Moxalactam in Medical Patients
(6)
Session IV: The Spiroplasmas and Their Taxonomic Relationships
(6)
Session IX: The Immunocompromised Host
(6)
Session V: Epidemiology
(6)
Session V: Putting Research Into Practice
(6)
Session V: Research Needs
(6)
Summary of Current Nomenclature, Taxonomy, and Classification of Various Microbial Agents
(6)
Symposium I. Structural Aspects of Lipid A
(6)
Symposium III. Interaction of Lipid A with Membranes
(6)
Symposium IV. Interaction of Lipid A with Lymphocytes and Macrophages
(6)
Symposium V. Lipid A Immunology and Host Protection
(6)
Taxonomy and Clinical Significance
(6)
The Phagocytic Cell
(6)
Tissue-Directed Antibiotic Therapy: Antibiotic Dynamics in Cells and Tissue
(6)
Typhoid Conjugate Vaccine and the Future of Enteric Fever Control and Prevention
(6)
United States
(6)
V. Training for Parents, Child Day Care Providers, Regulators, and Public Health Personnel
(6)
Viral Hepatitis
(6)
Wildlife Rabies: Control with Oral Vaccines
(6)
ACKNOWLEDGMENTS
(5)
Abbreviations List
(5)
Acanthamoeba Keratitis: Extended Abstracts
(5)
An Annotated Bibliography of Toxic Shock Syndrome
(5)
Anaerobes in normal flora and their role in pathogenic processes other than infection
(5)
Antimicrobial Activity
(5)
Antimicrobial Agent-Induced Pseudomembranous Colitis and Diarrhea
(5)
Assessment of Frequency of Paralytic Disease
(5)
Bacterial Typing Systems
(5)
Biochemical Mechanisms
(5)
Biology and Immunology of Infections Due to Pseudomonas Aeruginosa
(5)
Campylobacter pylori Infections
(5)
Chemotherapy
(5)
Controversies in the Diagnosis and Management of Infectious Diseases. Session VI. Implanted Devices
(5)
Country Experiences
(5)
Current Advances in the Management of AIDS
(5)
Diarrhea in the Nontraveler
(5)
Equity, Diversity, Inclusion and Social Justice
(5)
Hemmorrhagic Fever with Renal Syndrome
(5)
History and Global Rabies Problem
(5)
Host Resistance and Defenses
(5)
Hypotheses
(5)
II. Pharmacokinetics and Pharmacology
(5)
III. Disease Prevention Policies and Practices for Day Care Operation
(5)
III. Prevention
(5)
Immune Parameters in Other Herpesvirus Infections
(5)
Immunologic Parameters of Mycoplasmal Infections
(5)
Infections In Older Adults
(5)
MINOCYCLINE FOR THE TREATMENT OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII
(5)
Management of Fungal Infections: Part 1
(5)
Measuring the Global Burden of Enteric Fever
(5)
Medicolegal Case Reviews
(5)
Microbiologic and Structural Aspects of Obligate Anaerobes
(5)
Modern Imaging Technology
(5)
Notice
(5)
Office Of Continuing Medical Education UCLA School Of Medicine
(5)
Online Only Article
(5)
Parasitic Infections
(5)
Participants
(5)
Pathogenicity
(5)
Persistent Viral Infections: A Collection of Reviews
(5)
Prevention of Infections in the Immunocompromised Patient
(5)
Regional Activities
(5)
Reports from Around the World
(5)
Retraction
(5)
Reviewers
(5)
Role of Intravenous Immunoglobulin
(5)
SUMMARY
(5)
Scope of the Problem
(5)
Session I. Review of the Problem
(5)
Session I: Current Status Of Poliomyelitis
(5)
Session I: Theoretical and Preclinical Experimental Bases of Prophylaxis
(5)
Session II. Antibacterial Activity of Imipenem
(5)
Session II: Identification and Laboratory Characteristics
(5)
Session II: Pharmacokinetic Characteristics
(5)
Session II: Properties of Mycoplasmal Membranes
(5)
Session III. Burn Infections
(5)
Session III: Dermatomycoses
(5)
Session III: Efficacy in Urinary Tract, Respiratory Tract, and Soft-Tissue Infections
(5)
Session III: Recent Developments in the Study of Mycoplasmal Viruses
(5)
Session IV: Animal Infections
(5)
Session IV: Conclusion
(5)
Session IV: Efficacy Studies of Pneumococcal Vaccine in Infants and Children
(5)
Session IX. Summary of Clinical Experience with Aztreonam
(5)
Session V. Surface Antigens
(5)
Session VI: Host-Pathogen Interactions
(5)
Session VII
(5)
Session VII: Mycoplasmal Immunity and Immunopathology
(5)
Session VIII. Other Gram-Negative Infections
(5)
Sexually Transmitted Diseases in the Military
(5)
Status of Vaccines Under Development and Testing
(5)
Study Reports
(5)
Summary of Current Nomenclature, Taxonomy, and Classification
(5)
Symposium II. Synthesis of Lipid A
(5)
Taxonomy
(5)
Taxonomy and Indigenous Flora
(5)
The Evolving Use of Biologicals in ihe Treatment and Prevention of Infectious Diseases
(5)
The Global Problem of Amebiasis: Current Status, Research Needs, and Opportunities for Progress
(5)
Travelers' Diarrhea
(5)
Use of Inactivated Vaccine
(5)
View Points
(5)
Viewpoints and Counterpoints
(5)
Viral Glycoproteins: A Collection of Reviews
(5)
Abstract for Electronic Article
(4)
Aids Commentaries
(4)
Arcanum
(4)
Artículo Suplementario
(4)
Asia and the Middle East
(4)
Background
(4)
COVID-19 and Disproportionately Affected Persons
(4)
Chronic Fatigue Syndrome: Current Concepts
(4)
Classic in Infectious Diseases
(4)
Clinical Infectious Diseases Cover Art Editor
(4)
Clinical Problems, Real and Imagined
(4)
Clinical Sequelae of SARS-CoV-2 Infection
(4)
Community-Based Studies of Acute Respiratory Tract Infections in Young Children
(4)
Current News
(4)
Electronics Articles
(4)
Epidemiology of Fungal Infections: Current Perspectives and Future Directions
(4)
European Guidelines for Anti-Infective Drug Products
(4)
Formalin-Inactivated Vaccine
(4)
Future Therapies
(4)
General Guidelines for the Treatment of Infections of the Central Nervous System
(4)
Genetics
(4)
HIV/AIDs
(4)
Hiv/Aids
(4)
I. Basic Evaluation Of New β-Lactam Antibiotics
(4)
I. History, Pharmacowgy, and Activity in Vitro and in Animal Models
(4)
IDSA Lectures
(4)
IDSA Policy Principles
(4)
II. Epidemiology and Etiology
(4)
IV. Clinical Evaluation of New β-Lactam Antibiotics
(4)
Immunology
(4)
Indexes To Symposium
(4)
Infectious Diseases Society of America Quality Standards for Infectious Diseases
(4)
Latin America
(4)
Live Attenuated Vaccine
(4)
Management of Fungal Infections: Part 2
(4)
Manufacturing Challenges
(4)
Modes Of Action Of And Response To Vaccines
(4)
Molecular Biology of Mycobacteria
(4)
Multidisciplinary Studies
(4)
Nature of the Resistance Problem
(4)
Novel Tools for Detection of Enteric Fever
(4)
Oral and Dental Infection
(4)
Part III: Viral Studies of Chronic Fatigue Syndrome
(4)
Pathology and Clinical Aspects of Acute Respiratory Tract Infections in Children
(4)
Patients With T Cell Defects: Part 1
(4)
Potential Candidates for Eradication
(4)
Present Approaches to Tuberculosis Control and Prevention
(4)
Reviewer List
(4)
Role of Bacterial Pathogens in Acute Respiratory Tract Infections
(4)
Role of Viral Pathogens in Acute Respiratory Tract Infections
(4)
Safety
(4)
Session 11: Drug Interactions
(4)
Session 5: Prevalence and Clinical Importance of Class I β-Lactamases
(4)
Session I. Reimbursement for Health Care
(4)
Session I: Classification and Identification
(4)
Session II: Experimental Therapy
(4)
Session II: Strategies and Technologies for Control
(4)
Session II: Vaccine Development
(4)
Session III. Lower Respiratory Tract Infections
(4)
Session III: Combinations of Trimethoprim with Drugs Other Than Sulfonamides
(4)
Session III: Efficacy of Pneumococcal Vaccine
(4)
Session III: β-Lactam Antibiotics: Efficacy
(4)
Session IV. Obstetric and Gynecologic Infection
(4)
Session IV: Candidosis
(4)
Session IV: Special Studies
(4)
Session IV: Use of the Laboratory
(4)
Session V. Intraabdominal Infections
(4)
Session V: Current Aspects in the Control of Plant Mycoplasmal Diseases
(4)
Session V: Reviews of Clinical Experience with Imipenem/Cilastatin
(4)
Session V: Surgical Prophylaxis
(4)
Session VI. Extracellular Products
(4)
Session VI: Respiratory Infections
(4)
Session VII: Gastrointestinal Infections
(4)
Special Section: Aging and Infectious Diseases
(4)
Special Section: Medical Microbiology
(4)
Surgical Prophylaxis
(4)
Tick Alert
(4)
Tribute
(4)
Update on Cephalosporin Resistance and the Role of Sulbactam/Cefoperazone
(4)
Value of the Infectious Diseases Specialist
(4)
Virulence Factors
(4)
1. State-of-the-Art Overviews
(3)
Author's Correction
(3)
Bacampicillin: Pharmacologic Studies
(3)
Brazil
(3)
CME Evaluation
(3)
CORRESPONDANCE
(3)
Case study
(3)
Clinical Anaerobic Bacteriology
(3)
Clinical Characteristics
(3)
Clinical Practices
(3)
Diagnosis of Fungal Infections
(3)
Diagnostic Microbiology Update
(3)
Discussion
(3)
EAST EUROPE/CENTRAL ASIA
(3)
EDITORIAL NOTES
(3)
Evidence of effectiveness of interventions to prevent transmission
(3)
From the Infectious Diseases Society of America
(3)
From the International Congress for Infectious Diseases
(3)
Future Directions and Priorities
(3)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Intraabdominal and Pelvic Infections
(3)
General Guidelines for the Evaluation of New Antimycobacterial Drugs for the Treatment of Systemic Mycobacterial Infections
(3)
HEALTH BENEFITS OF ROTAVIRUS VACCINATION IN DEVELOPING COUNTRIES
(3)
I. β-Lactamases and β-Lactam Antibiotics
(3)
IDSA MEMBERSHIP APPLICATION
(3)
In Vivo Studies
(3)
In the Literatures
(3)
International Symposium on Yaws and Other Endemic Treponematoses
(3)
Isolation and Identification
(3)
MANAGEMENT OF HEPATITIS C/HIV COINFECTION IN THE ERA OF HIGHLY EFFECTIVE HEPATITIS C VIRUS DIRECT-ACTING ANTIVIRAL THERAPY
(3)
Management of Other Infections
(3)
Management of Sepsis
(3)
Microbiologic Considerations
(3)
Patients With Neutropenia: Old and New Treatment Modalities
(3)
Pharmacology
(3)
Preclinical Studies
(3)
QUALITY IMPROVEMENT
(3)
Related Perspectives
(3)
SARS Bulletin from Hong Kong
(3)
Session I. Current Problems in Hospital Infection
(3)
Session I: Aminoglycoside Antibiotics: Efficacy
(3)
Session III: Health Care Policy and Practice
(3)
Session IV: Worldwide Control and/or Eradication of Yaws
(3)
Session IV: β-Lactam Antibiotics: Resistance and Toxicity
(3)
Session VI. Infections in the Neutropenic Patient
(3)
Session VI: Economic Considerations
(3)
Session VII. Urinary Tract Infections
(3)
Sexually Transmitted Infections
(3)
Spain
(3)
Special Section: Confronting Biological Weapons
(3)
Special Section: Emerging Infections
(3)
Special Section: Food Safety
(3)
Special Section: Healthcare Epidemiology
(3)
Subject Index
(3)
Symposium I: Definition of the Problem
(3)
The Americas
(3)
Therapeutic Use
(3)
Vaccine
(3)
Vancomycin-Resistant Enterococci Alert
(3)
Viewpoints and Commentary
(3)
World Health Organization Programs
(3)
1 April News
(2)
1 February News
(2)
1 January News
(2)
1 March News
(2)
1 May News
(2)
15 April News
(2)
15 February News
(2)
15 January News
(2)
15 March News
(2)
1996 Kass Lecture
(2)
Acknowledgments
(2)
Announcement
(2)
Answer to Arcanum
(2)
Answers to Photo Quiz
(2)
Answers to Photo Quizzes
(2)
Antimicrobial stewardship
(2)
Appendix B
(2)
Appendix C
(2)
Appendix D
(2)
Appendix E
(2)
Appendix F
(2)
Appendix G
(2)
Appendix H
(2)
Appendix I
(2)
Article and Commentaries
(2)
Bloopers
(2)
Brief Communications
(2)
Burden of antimicrobial resistant infections
(2)
CID TOP ARTICLE AWARD
(2)
CME Article
(2)
COVID-19 / SARS CoV-2
(2)
COVID-19 And Other Infectious Diseases
(2)
CSE Theme Articles
(2)
Central Nervous System
(2)
Chapter Notes
(2)
Clinical Dilemmas in ID
(2)
Clinical Pharmacology
(2)
Editor's Announcement
(2)
Editor's Comments
(2)
Enteric Fever Vaccine Development Pipeline
(2)
Epidemiologic Characteristics
(2)
Fungal Infections in Immunocompromised Hosts
(2)
General Discussion
(2)
Guidelines
(2)
Healthcare Epidemiologies
(2)
Hemostatic Impairment Associated with Hemorrhagic Fever Viruses
(2)
Historical Background and Current Practices
(2)
Host Defenses
(2)
I. Child Day Care and Infectious Disease: An Overview
(2)
IDSA Clinician Award
(2)
II. Evaluation of in Vitro and in Vivo Efficacy of New β-Lactam Antibiotics
(2)
III. Pharmacokinetic Evaluation Of New β-Lactam Antibiotics
(2)
INDEX TO VOLUME 15
(2)
IV. Child Day Care Regulation and Legal Relationship to Infectious Diseases
(2)
IV. Vaginal Candidosis
(2)
Index to Volume 23
(2)
Index to Volume 24
(2)
Indexes to Volume 7
(2)
Innovations in Design, Education, and Analysis (IDEA)
(2)
International Congress for Infectious Diseases
(2)
Intoxications
(2)
Intraabdominal Infections
(2)
Introduction to the Symposium
(2)
Invited Article and Commentary
(2)
Keynote Address
(2)
Laboratory Study
(2)
Managed Care
(2)
Manufacturing and Public Health
(2)
Mechanisms of Fever
(2)
Mechanisms of transmission and disease progression
(2)
November News and Events
(2)
OVERVIEW
(2)
Obstetric and Gynecologic Infections
(2)
October News and Events
(2)
Overview
(2)
Overview and Predictions
(2)
POINT/COUNTERPOINT
(2)
PREVENTION
(2)
Part V: Public Policy and Chronic Fatigue Syndrome: A Perspective
(2)
Pharmacologic Considerations
(2)
Photo Quizzes
(2)
Position Paper
(2)
Position Statement from the Infectious Diseases Society of America
(2)
Preliminary 1993 IDSA Annual Meeting Program
(2)
Preliminary Program of the 1994 IDSA Annual Meeting
(2)
Prospects for New Vaccines
(2)
REVIEW OF ANTI-INFECTIVE AGENTS
(2)
Reply
(2)
Report to the IDSA from the Task Force on Health Care Reform
(2)
Research Towards Rabies Prevention
(2)
Review of Anti-Infective Agents
(2)
SARS-CoV-2 Transmission
(2)
SPECIAL ARTICLES
(2)
Second International Symposium on New Quinolones
(2)
Session 12: Pharmacokinetics in the Elderly
(2)
Session 12: Toxicology
(2)
Session 13: Use in Pediatrics
(2)
Session 14: Metabolism of Quinolones
(2)
Session 14: Urinary Tract Infections
(2)
Session 15: Bone and Joint Infections
(2)
Session 16: Acute Infectious Diarrhea
(2)
Session 16: Gastrointestinal Flora
(2)
Session 17: Bacteremia and Severe Infections
(2)
Session 17: Gastrointestinal Infections
(2)
Session 18: Bronchopulmonary Infections
(2)
Session 18: Typhoid and Enteric Fever
(2)
Session 19: Bacteremia And Therapy In The Immunosuppressed Host
(2)
Session 19: Endocarditis and Infections of the Central Nervous System and Eye, Nose, and Throat
(2)
Session 1: Chemistry
(2)
Session 1: Mode of Action
(2)
Session 20: Eye, Ear, Nose, And Throat Infections
(2)
Session 20: Pulmonary Infections
(2)
Session 21: Central Nervous System Infections
(2)
Session 21: Immunosuppressed Host and Gut Decontamination
(2)
Session 22: Adverse Effects
(2)
Session 22: Cystic Fibrosis
(2)
Session 23: Bone and Joint Infections
(2)
Session 24: Chlamydial Infections
(2)
Session 25: Prophylaxis and Therapy for Surgical Infections
(2)
Session 26: Sexually Transmitted Diseases and Obstetric and Gynecologic Infections
(2)
Session 27: Urinary Tract Infections and Prostatitis
(2)
Session 28: Long-Term Use and Safety
(2)
Session 29: Effect on Gastrointestinal Flora
(2)
Session 2: Mode of Action
(2)
Session 2: Mode of Action: Antibacterial Activity
(2)
Session 30: Mechanisms of Side Effects
(2)
Session 31: Post-Marketing Surveillance
(2)
Session 3: Bacterial Uptake and Killing
(2)
Session 3: Microbiology
(2)
Session 4: Resistance And Mechanisms
(2)
Session 5: Microbial Resistance
(2)
Session 5: Use Against Intracellular Pathogens
(2)
Session 6: Comparative Agents And Antibiofic Interactions
(2)
Session 6: Human Pharmacokinetics
(2)
Session 7: Antibiotic Combinations
(2)
Session 7: Pharmacology And Pharmacokinetics: Volunteers
(2)
Session 8: Tissue Penetration
(2)
Session 8:Pharmacology and Pharmacokinetics: Patients
(2)
Session 9: Animal Models
(2)
Session I: Antifungal Drugs
(2)
Session I: Overview of in Vitro and Clinical Experience
(2)
Session I: Pneumococcal Disease and the Development and Chemistry of the Vaccine
(2)
Session II: Responses to Pneumococcal Vaccine
(2)
Session III: Pharmacokinetics of Imipenem/Cilastatin
(2)
Session IV. Ocular Infections
(2)
Session IV: Adverse Effects of Trimethoprim-Sulfamethoxazole
(2)
Session V: Moxalactam in Perspective
(2)
Session VIII: Parenteral Use of Trimethoprim-Sulfamethoxazole
(2)
Special Section: Aging and Infections
(2)
Special Section: Antimicrobial Resistance
(2)
Special Section: Infections in Transplantation and Other Immunocompromised Hosts
(2)
Special Section: Surfing the Web
(2)
State of the Art Review
(2)
The Rise of Drug Resistance
(2)
The Years 1969-1978
(2)
The Years 1979-1987
(2)
Thermoregulation
(2)
Urinary Tract Infections
(2)
Use of Both Attenuated and Inactivated Vaccines
(2)
Vaccine and New Drug Development
(2)
Vector-Borne Diseases
(2)
Viewpoints and Commentaries
(2)
1 August News
(1)
1 July News
(1)
1 June News
(1)
1 September News
(1)
15 August News
(1)
15 December News
(1)
15 July News
(1)
15 May News
(1)
1991 IDSA Annual Meeting Program
(1)
1992 IDSA Annual Meeting Program
(1)
A Perspective
(1)
A Special Message from the Editor
(1)
A Successful Eradication Campaign
(1)
ARTICLES AND COMMENTARIES
(1)
Abbreviated CV
(1)
Abstract
(1)
Abstracts in Spanish
(1)
Abstracts of the 1993 IDSA Annual Meeting
(1)
Abstracts of the 1994 Annual IDSA Meeting
(1)
Abstracts of the 1995 IDSA Annual Meeting
(1)
Abstracts of the 1996 Annual IDSA Meeting
(1)
Abstracts of the 1997 Annual IDSA Meeting
(1)
Abstracts of the 2000 Annual IDSA Meeting
(1)
Abstracts of the 2001 Annual IDSA Meeting
(1)
Abstracts of the IDSA 37th Annual Meeting
(1)
Addendum
(1)
Aging and Infectious Disease
(1)
Anaerobes: Yesterday and Today
(1)
Announcement to All Members and Fellows of the IDSA
(1)
Answer To The Arcanum
(1)
Answer to Photo Quiz I
(1)
Answer to Photoquiz
(1)
Answer to the Photo Qiuiz
(1)
Answer to the Photoquiz
(1)
April News and Events
(1)
Author Index to Papers and Abstracts
(1)
Author Index to Volume 16
(1)
Author Index to Volume 20
(1)
Author Index to Volume 21
(1)
Author Index to Volume 22
(1)
Author Index to Volume 25
(1)
Author Index to Volume 26
(1)
Author Index to Volume 27
(1)
Author Index to Volume 37
(1)
Author Index to Volume 38
(1)
Author Index to Volume 40
(1)
Author Index to Volume 46
(1)
Author Index to Volume 47
(1)
Author Index: Abstracts of the 1993 IDSA Annual Meeting
(1)
Author Index: Abstracts of the 1994 Annual IDSA Meeting
(1)
Author Index: Abstracts of the 1995 Annual IDSA Meeting
(1)
Author Index: Abstracts of the 1996 Annual IDSA Meeting
(1)
Author Index: Abstracts of the 1997 Annual IDSA Meeting
(1)
BETTER TESTS, BETTER CARE: IMPROVED DIAGNOSTICS FOR INFECTIOUS DISEASES
(1)
Book-Reviews
(1)
Brief Communication
(1)
CID Editors' Award
(1)
COVID-19 / Sars COV-2
(1)
Camilla S. Graham, Section Editor
(1)
Case Report
(1)
Case reports
(1)
Clinical Infectious Diseases 2008 Editorial Report
(1)
Commentary
(1)
Comparisons Among Countries
(1)
Concise Communications
(1)
Correpondence
(1)
EDITORIAL
(1)
ELECTRONIC ARTILCES
(1)
EMANUEL WOLINKSY AWARD
(1)
Editorial Note
(1)
Editorial Note: Modifications to Reviews of Infectious Diseases
(1)
Editorial commentary
(1)
Editorial: Past, Present, and Future of Infectious Diseases Society of America Publications
(1)
El Orden Del Día
(1)
Enzyme-Mediated Resistance To β-Lactam Antibiotics: A Symposium On Sulbactam/Ampicillin
(1)
Epilogue
(1)
Erratum/Corrigendum
(1)
Evaluation of New β-Lactam Antibiotics
(1)
Executive Summary
(1)
FAQ
(1)
February News and Events
(1)
Foreword
(1)
From the Center for Disease Control
(1)
GUÍAS DE IDSA
(1)
General
(1)
General Guidelines for Clinical Bacteriology
(1)
General Guidelines for the Evaluation of New Anti-Infective Drugs for Prophylaxis of Surgical Infections
(1)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic Patients
(1)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Infective Endocarditis
(1)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract Infections
(1)
General Guidelines for the Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection
(1)
General Guidelines for the Evaluation of New Antifungal Drugs for the Treatment of Systemic Fungal Infections
(1)
Gram-Negative Aerobic Bacterial Infections: A Focus On Directed Therapy, with Special Reference to Aztreonam
(1)
Guías de la IDSA
(1)
Guíde la IDSA
(1)
HEPATITIS
(1)
HEPATITIS C
(1)
HSV Antigens
(1)
Health Care Epidemiology
(1)
Healthcare Epidemiology Special Section
(1)
I. Overview
(1)
IDSA Feature
(1)
IDSA Membership Information
(1)
IDSA NOTICE
(1)
IDSA Policy Principles—Executive Summary
(1)
IDSA Position Paper
(1)
IDSA Position Paper (December 1992 issue): New Address for Reprint Requests
(1)
IDSA Report
(1)
INDEX TO VOLUME 18
(1)
INFORMATION FOR AUTHORS
(1)
Imipenem: The First Thienamycin Antibiotic
(1)
Immunocompromised Host
(1)
Implementation Challenges
(1)
Index To Volume 17 Author Index
(1)
Index to Volume 11
(1)
Index to Volume 13
(1)
Index to Volume 14
(1)
Index to Volume 28
(1)
Index to Volume 29
(1)
Index to Volume 30
(1)
Index to volume 12
(1)
Index to volume 4
(1)
Indexes to Volume 10
(1)
Indexes to Volume 5
(1)
Infectious Diseases Society of America (IDSA) Membership Information
(1)
Infectious Diseases in Child Day Care: Management and Prevention
(1)
International Symposium on Toxic Shock Syndrome
(1)
International Symposium on new Quinolones
(1)
Internationl Note
(1)
Introduction to IDSA Guidelines
(1)
Introduction to the Workshop
(1)
Invited Article: Immunocompromised Hosts
(1)
Invited Review
(1)
Issues in Medical Practice
(1)
Joint Statement and Practice Policy Position Paper of the American College of Rheumatology and the Council of the Infectious Diseases Society of America on the Treatment of “Possible” Lyme Disease
(1)
July News and Events
(1)
June 15 News
(1)
June News and Events
(1)
Keynote Session
(1)
Lifetime Highlights
(1)
MEMORIAM
(1)
March News and Events
(1)
Maxwell Finland Lecture
(1)
May News and Events
(1)
Meeting Summary
(1)
Memorial
(1)
Memorial Tribute
(1)
Miscellany
(1)
Notes from the Editor
(1)
Notices and Report of the International Congress for Infectious Diseases
(1)
Omissions from Reviewer List for Volume 22
(1)
Overview of the Symposium
(1)
Panel Discussion: The Clinical Perspective
(1)
Part VI: Closing Remarks
(1)
Photo Ouiz
(1)
Photo Quiz I
(1)
Preface
(1)
Preliminary 1995 Program of the IDSA Annual Meeting
(1)
Preliminary Program for the 1995 IDSA Annual Meeting
(1)
Public Policy
(1)
Puerto Rico
(1)
RETRACTION NOTICE
(1)
REVIEWARTICLE
(1)
REVIEWARTICLES
(1)
REVIEWS OF ANTI - INFECTIVE AGENTS
(1)
Report from the Infectious Diseases Society of America
(1)
Reviewers for 2001
(1)
Reviewers for 2002
(1)
Reviewers for 2005
(1)
Reviewers for 2006
(1)
Reviewers for 2007
(1)
Reviewers for 2009
(1)
Reviewers for 2010
(1)
Reviewers for Volume 1
(1)
Reviewers for Volume 10
(1)
Reviewers for Volume 11
(1)
Reviewers for Volume 13
(1)
Reviewers for Volume 14
(1)
Reviewers for Volume 15
(1)
Reviewers for Volume 16
(1)
Reviewers for Volume 17
(1)
Reviewers for Volume 18
(1)
Reviewers for Volume 19
(1)
Reviewers for Volume 20
(1)
Reviewers for Volume 21
(1)
Reviewers for Volume 22
(1)
Reviewers for Volume 23
(1)
Reviewers for Volume 24
(1)
Reviewers for Volume 25
(1)
Reviewers for Volume 26
(1)
Reviewers for Volume 27
(1)
Reviewers for Volume 28
(1)
Reviewers for Volume 29
(1)
Reviewers for Volume 4
(1)
Reviewers for Volume 5
(1)
Reviewers for Volume 6
(1)
Reviewers for Volume 7
(1)
Reviewers for Volume 8
(1)
Reviewers for Volume 9
(1)
SARS Bulletin from Hong Kong: What Might We Have Done Better?
(1)
September News and Events
(1)
Session 10: Concentrations in Human Tissues and Fluids
(1)
Session 10: Surgical Infections
(1)
Session 13: Sexually Transmitted Diseases
(1)
Session 15: Open Studies
(1)
Session 4: Intracellular Pathogens
(1)
Session 9: Cellular Systems
(1)
Session I. Epidemiology
(1)
Session III. Safety and Tolerance
(1)
Session VI: Summary
(1)
Soft Tissue and Bone and Joint Infections
(1)
Special Announcement
(1)
Special Report from the Institute of Medicine
(1)
Special Reports
(1)
Special Section: Aging and Infection
(1)
Special Section: Clinical Practice
(1)
Special Section: Health Care Epidemiology
(1)
Special Section: Vaccines
(1)
State-of-the Art Clinical Article
(1)
State-of-the-Art-Clinical Article
(1)
Statement of Editorial Policy and Instructions
(1)
Statement of Editorial Policy: Clinical Infectious Diseases
(1)
Statement of Editorial Policy: Reviews of Infectious Diseases
(1)
Statements of Editorial Policy and Instructions to Authors
(1)
Subject Index to Volume 20
(1)
Subject Index to Volume 21
(1)
Subject Index to Volume 22
(1)
Subject Index to Volume 25
(1)
Subject Index to Volume 26
(1)
Subject Index to Volume 27
(1)
Subject Index to Volume 28
(1)
Subject Index: Abstracts of the 1993 IDSA Annual Meeting
(1)
Subject Index: Abstracts of the 1996 Annual IDSA Meeting
(1)
Subject Index: Abstracts of the 1997 Annual IDSA Meeting
(1)
Supplement Appendix
(1)
Symposiums Participants
(1)
Table of Contents: Abstracts of the 1996 Annual IDSA Meeting
(1)
Table of Contents: Abstracts of the 1997 Annual IDSA Meeting
(1)
The Schaefer Memorial Lecture
(1)
Treatment
(1)
Tribute Page
(1)
Tuberculosis Commentaries
(1)
Updated Guidelines
(1)
Uruguay
(1)
V. Consensus Development Conference Statement
(1)
V. Overview
(1)
VI. Summary
(1)
Video Review
(1)
View Point
(1)
Virulence Factors of Anaerobic Bacteria: Summary of the Symposium
(1)
Withdrawn as Duplicate
(1)
Workshop Participants
(1)
World Health Organization
(1)
